Disc Medicine, Inc. Cash Flow Statement

Cash Flow Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -40.83M-71.14M-46.83M-76.43M-109.36M
Depreciation and Depletion 0.32M0.23M0.10M0.20M
Share-based Compensation 0.98M0.51M2.09M5.53M16.82M
Gains from Investment Securities 1.90M1.67M0.60M8.30M14.50M
Cash from Operations -32.71M-27.53M-42.25M-73.46M-93.93M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 5.30M
Depreciation & Amortization (CF) 0.32M0.03M0.09M0.10M0.16M
Change in Working Capital
Change in Account Payables -2.41M1.31M0.53M-3.74M-4.68M
Change in Accured Expenses 0.00M1.54M1.50M1.84M1.68M
Other Working Capital Changes -1.68M1.37M-0.35M1.17M-1.57M
Investing Activities
Capital Expenditures 0.02M0.07M0.15M0.09M0.51M
Sales of Property, Plant and Equipment 0.41M
Change in Acquisitions & Divestments 94.80M
Cash from Investing Activities -0.02M-0.07M-0.15M-0.09M-292.33M
Financing Activities
Other financing activities 1.39M
Cash from Financing Activities 34.25M89.93M148.98M239.38M218.31M
Additional items
Change in Cash 1.52M62.33M106.58M165.83M-167.94M
Free Cash Flow -32.73M-27.60M-42.40M-73.55M-94.43M
Net Cash Flow 1.52M62.33M106.58M165.83M-167.94M